A clinical trial to study the effect of some herbal drugs in pain after vaginal delivery

Phase 2

Completed

• Registration Number: CTRI/2018/03/012542
• Lead Sponsor: Banaras Hindu University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-01-15
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Patient willing to participate in present study after giving the proper consent

2.Patient complaining of lower abdominal pain after vaginal delivery

3.Multi and primipara women

Exclusion Criteria

1.Age less than 18 years or more than 40 years

2.Cases delivered by caesarean section or any assisted technique

3.Grand multipara (parity >= 4)

4.Cases having history of any disease of central nervous system like epilepsy, meningitis, migraine etc.

5.Cases having history of any disease of respiratory system like bronchial asthma, tuberculosis, pneumonia, pleural effusion, bronchitis etc.

6.Cases having history of any cardiac disorder like hypertension, angina, myocardial infarction, congenital anomaly of heart etc.

7.Cases having history of any gastrointestinal disorder like appendicitis, cholecystitis, hepatitis, pancreatitis, cholelithiasis, diverticulitis, gastric ulcer, irritable bowel syndrome etc.

8.Cases suffering from any systemic disease like anaemia, malaria, typhoid, jaundice, diabetes mellitus, thyroid dysfunction, coagulation disorders etc.

9.Cases having history of hypersensitivity to any commonly used drugs.

10.Cases having history of blood transfusion.

11.Patients having history of any surgical condition like any benign or malignant growth in genital tract, genital prolapse etc.

12.Patients not given consent for participation in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analysis of abdominal pain after vaginal delivery through numeric pain rating score and visual analogue scaleTimepoint: First follow-up at 10th day, second follow up at 15th day and last follow up at 30th day of delivery

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: Nil